

NatWest vs Manulife
UK banking group serving retail and commercial clients vs Canadian insurer and wealth manager serving US and Asia. Which is the better buy for your portfolio in August 2026? Plain-English answer below.
NatWest grinds through the slow-moving world of U.K. retail and commercial banking while Manulife straddles life insurance and asset management across Canada, the U.S., and Asia. They share exposure to interest-rate movements and a common pressure to improve return on equity year after year. NatWest vs Manulife examines the trade-offs between a domestically concentrated bank and a globally diversified insurer competing for capital.
NatWest grinds through the slow-moving world of U.K. retail and commercial banking while Manulife straddles life insurance and asset management across Canada, the U.S., and Asia. They share exposure t...
Why It’s Moving

NatWest stays in focus as buybacks, dividends, and upbeat analyst calls keep momentum alive
- NatWest extended its share buyback program and updated voting rights, a sign management is still using excess capital to support shareholder returns and tighten the share count.
- The stock has been trading near a 52-week high after the latest dividend declaration, with income-focused investors reacting to the bank’s steady payout profile and capital strength.
- Recent analyst commentary stayed broadly constructive, with several firms reiterating bullish views after the latest earnings update signaled resilient profitability and improving deposit margins.

Manulife’s strong earnings and capital moves are keeping the stock active, but valuation concerns are capping the upside.
- Manulife’s late-August momentum is still being shaped by its strong Q2 results, where core earnings grew and Asia sales stayed healthy, reinforcing the view that operating performance is solid even after a strong run in the shares.
- A new long-term care reinsurance transaction with Munich Re is helping reshape the company’s risk profile and free up capital, which investors are reading as a balance-sheet positive but also a reminder that management is actively fine-tuning the portfolio.
- Broker sentiment has stayed constructive in early August, with multiple firms lifting their outlooks after earnings; that support is being tempered by the stock’s rich valuation, which is why some analysts still flag meaningful downside if execution cools.

NatWest stays in focus as buybacks, dividends, and upbeat analyst calls keep momentum alive
- NatWest extended its share buyback program and updated voting rights, a sign management is still using excess capital to support shareholder returns and tighten the share count.
- The stock has been trading near a 52-week high after the latest dividend declaration, with income-focused investors reacting to the bank’s steady payout profile and capital strength.
- Recent analyst commentary stayed broadly constructive, with several firms reiterating bullish views after the latest earnings update signaled resilient profitability and improving deposit margins.

Manulife’s strong earnings and capital moves are keeping the stock active, but valuation concerns are capping the upside.
- Manulife’s late-August momentum is still being shaped by its strong Q2 results, where core earnings grew and Asia sales stayed healthy, reinforcing the view that operating performance is solid even after a strong run in the shares.
- A new long-term care reinsurance transaction with Munich Re is helping reshape the company’s risk profile and free up capital, which investors are reading as a balance-sheet positive but also a reminder that management is actively fine-tuning the portfolio.
- Broker sentiment has stayed constructive in early August, with multiple firms lifting their outlooks after earnings; that support is being tempered by the stock’s rich valuation, which is why some analysts still flag meaningful downside if execution cools.
Investment Analysis

NatWest
NWG
Pros
- NatWest Group reported a 32.4% year-on-year increase in earnings per share in Q3 2025, demonstrating strong profitability growth.
- The company upgraded its full-year income guidance to £16.3 billion, reflecting confidence in ongoing growth strategies.
- NatWest maintains a strong return on tangible equity at 19.5%, indicating efficient capital use.
Considerations
- NatWest Group's stock is currently trading above its fair value according to some analyses, suggesting limited upside near term.
- The bank operates in a highly competitive UK retail banking market which could pressure margins and growth.
- Interest margin growth is expected to peak by 2027, potentially limiting future profit expansion.

Manulife
MFC
Pros
- Manulife Financial Corporation has a large market cap of approximately $56 billion, supporting significant scale advantages.
- The company operates in diverse insurance and wealth management segments, providing multiple growth drivers.
- Manulife benefits from strong brand presence in both Canadian and Asian markets, enhancing its geographic diversification.
Considerations
- Manulife's recent stock performance has been slightly negative, reflecting potential market concerns or sector challenges.
- The insurance industry faces regulatory and macroeconomic risks including interest rate volatility and capital requirements.
- Manulife is exposed to underwriting and claims risks which can affect profitability during adverse events.
NatWest (NWG) Next Earnings Date
The next earnings date for NWG is expected on October 30, 2026. It will cover Q3 2026 results. This timing follows the company’s stated upcoming results schedule and its recent reporting pattern.
Manulife (MFC) Next Earnings Date
The next earnings date for MFC is expected to be November 4, 2026, based on its recent quarterly reporting pattern. This release would typically cover Q3 2026 results. The date is an estimate rather than a formally confirmed announcement.
NatWest (NWG) Next Earnings Date
The next earnings date for NWG is expected on October 30, 2026. It will cover Q3 2026 results. This timing follows the company’s stated upcoming results schedule and its recent reporting pattern.
Manulife (MFC) Next Earnings Date
The next earnings date for MFC is expected to be November 4, 2026, based on its recent quarterly reporting pattern. This release would typically cover Q3 2026 results. The date is an estimate rather than a formally confirmed announcement.
Buy NWG or MFC in Nemo
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.


